vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Local Bounti Corporation (LOCL). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $12.5M, roughly 1.7× Local Bounti Corporation). Local Bounti Corporation runs the higher net margin — -69.8% vs -373.3%, a 303.5% gap on every dollar of revenue. Local Bounti Corporation produced more free cash flow last quarter ($-3.6M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
AUTL vs LOCL — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $12.5M |
| Net Profit | $-79.1M | $-8.7M |
| Gross Margin | — | 12.2% |
| Operating Margin | -337.9% | -106.1% |
| Net Margin | -373.3% | -69.8% |
| Revenue YoY | — | 23.7% |
| Net Profit YoY | 3.6% | 76.0% |
| EPS (diluted) | $-0.30 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $12.5M | ||
| Q3 25 | $21.2M | $12.2M | ||
| Q2 25 | $20.9M | $12.1M | ||
| Q1 25 | $9.0M | $11.6M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $0 | $10.2M | ||
| Q2 24 | $0 | $9.4M | ||
| Q1 24 | $10.1M | $8.4M |
| Q4 25 | — | $-8.7M | ||
| Q3 25 | $-79.1M | $-26.4M | ||
| Q2 25 | $-47.9M | $-21.6M | ||
| Q1 25 | $-70.2M | $-37.7M | ||
| Q4 24 | — | $-36.3M | ||
| Q3 24 | $-82.1M | $-34.3M | ||
| Q2 24 | $-58.3M | $-25.3M | ||
| Q1 24 | $-52.7M | $-24.1M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 12.6% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | — | -106.1% | ||
| Q3 25 | -337.9% | -149.4% | ||
| Q2 25 | -292.6% | -127.7% | ||
| Q1 25 | -726.3% | -135.6% | ||
| Q4 24 | — | -166.6% | ||
| Q3 24 | — | -176.0% | ||
| Q2 24 | — | -146.8% | ||
| Q1 24 | -384.1% | -122.9% |
| Q4 25 | — | -69.8% | ||
| Q3 25 | -373.3% | -216.6% | ||
| Q2 25 | -229.0% | -178.3% | ||
| Q1 25 | -781.1% | -324.6% | ||
| Q4 24 | — | -360.1% | ||
| Q3 24 | — | -335.2% | ||
| Q2 24 | — | -267.6% | ||
| Q1 24 | -522.1% | -286.9% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | $-0.30 | $-1.18 | ||
| Q2 25 | $-0.18 | $-1.63 | ||
| Q1 25 | $-0.26 | $-4.32 | ||
| Q4 24 | — | $-4.24 | ||
| Q3 24 | $-0.31 | $-4.01 | ||
| Q2 24 | $-0.22 | $-3.00 | ||
| Q1 24 | $-0.24 | $-2.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $4.2M |
| Total DebtLower is stronger | — | $483.1M |
| Stockholders' EquityBook value | $265.5M | $-166.2M |
| Total Assets | $661.9M | $410.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.2M | ||
| Q3 25 | $86.1M | $6.2M | ||
| Q2 25 | $123.8M | $5.3M | ||
| Q1 25 | $95.8M | $18.0M | ||
| Q4 24 | — | $937.0K | ||
| Q3 24 | $657.1M | $317.0K | ||
| Q2 24 | $705.9M | $9.7M | ||
| Q1 24 | $758.5M | $8.2M |
| Q4 25 | — | $483.1M | ||
| Q3 25 | — | $484.9M | ||
| Q2 25 | — | $478.3M | ||
| Q1 25 | — | $480.0M | ||
| Q4 24 | — | $436.8M | ||
| Q3 24 | — | $398.4M | ||
| Q2 24 | — | $374.0M | ||
| Q1 24 | — | $329.8M |
| Q4 25 | — | $-166.2M | ||
| Q3 25 | $265.5M | $-158.1M | ||
| Q2 25 | $346.5M | $-132.7M | ||
| Q1 25 | $371.1M | $-134.5M | ||
| Q4 24 | — | $-100.5M | ||
| Q3 24 | $477.0M | $-65.6M | ||
| Q2 24 | $527.8M | $-32.8M | ||
| Q1 24 | $582.0M | $-9.4M |
| Q4 25 | — | $410.5M | ||
| Q3 25 | $661.9M | $417.8M | ||
| Q2 25 | $721.0M | $426.8M | ||
| Q1 25 | $746.3M | $447.2M | ||
| Q4 24 | — | $428.0M | ||
| Q3 24 | $827.5M | $430.8M | ||
| Q2 24 | $853.6M | $438.1M | ||
| Q1 24 | $901.4M | $413.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-3.1M |
| Free Cash FlowOCF − Capex | $-72.3M | $-3.6M |
| FCF MarginFCF / Revenue | -341.2% | -29.1% |
| Capex IntensityCapex / Revenue | 20.8% | 3.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-42.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-3.1M | ||
| Q3 25 | $-67.9M | $-8.9M | ||
| Q2 25 | $-72.8M | $-8.7M | ||
| Q1 25 | $-75.6M | $-9.6M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $-76.7M | $-17.2M | ||
| Q2 24 | $-51.1M | $-4.0M | ||
| Q1 24 | $-40.5M | $-7.1M |
| Q4 25 | — | $-3.6M | ||
| Q3 25 | $-72.3M | $-10.1M | ||
| Q2 25 | $-80.1M | $-14.6M | ||
| Q1 25 | $-83.8M | $-14.5M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | $-86.3M | $-30.0M | ||
| Q2 24 | $-51.9M | $-28.8M | ||
| Q1 24 | $-41.0M | $-42.1M |
| Q4 25 | — | -29.1% | ||
| Q3 25 | -341.2% | -82.8% | ||
| Q2 25 | -382.6% | -121.0% | ||
| Q1 25 | -933.1% | -125.1% | ||
| Q4 24 | — | -85.3% | ||
| Q3 24 | — | -293.1% | ||
| Q2 24 | — | -305.4% | ||
| Q1 24 | -406.8% | -501.8% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 20.8% | 9.7% | ||
| Q2 25 | 34.8% | 48.9% | ||
| Q1 25 | 91.8% | 42.8% | ||
| Q4 24 | — | 97.6% | ||
| Q3 24 | — | 125.0% | ||
| Q2 24 | — | 263.0% | ||
| Q1 24 | 5.3% | 417.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
